
YZR Capital
Description
YZR Capital is a Munich-based venture capital fund with a dedicated focus on the burgeoning Health Tech sector across Europe. The firm specializes in providing capital and strategic support to early-stage companies, primarily targeting Seed and Series A funding rounds. Their investment mandate encompasses a broad spectrum of health technology, including digital health solutions, medical devices, diagnostics, and biotech innovations. YZR Capital positions itself as a partner that brings not only financial resources but also deep industry expertise and an extensive network to its portfolio companies.
YZR Capital's investment strategy is characterized by its clear check size parameters. The firm typically deploys initial investments ranging from approximately $540,000 to $2,700,000 (€500k to €2.5M). This initial commitment is often followed by significant additional capital, with the capacity for follow-on investments extending up to $5,400,000 (€5M). This structured approach allows them to support companies through critical growth phases, from initial product development and market entry to scaling operations across the European landscape.
Beyond capital, YZR Capital emphasizes its value-add through operational support and strategic guidance. Founded by entrepreneurs with significant experience in building and scaling healthcare businesses, the firm leverages its team's practical knowledge to help founders navigate challenges and accelerate growth. Their portfolio showcases a diverse range of companies, with at least 14 distinct investments listed on their official website, including notable names in the European health tech ecosystem. This active engagement underscores their commitment to fostering innovation and driving the transformation of healthcare delivery.
Investor Profile
YZR Capital has backed more than 23 startups, with 6 new investments in the last 12 months alone. The firm has led 16 rounds, about 70% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Series A rounds (top funding stages).
- Majority of deals are located in Germany, United Kingdom, Poland.
- Strong thematic focus on Health Care, Medical, Artificial Intelligence (AI).
- Led 5 rounds in the past year.
- Typical check size: $540K – $2.7M.
Stage Focus
- Seed (39%)
- Pre Seed (30%)
- Series A (13%)
- Series Unknown (13%)
- Series B (4%)
Country Focus
- Germany (43%)
- United Kingdom (22%)
- Poland (9%)
- France (9%)
- United States (4%)
- Switzerland (4%)
- Spain (4%)
- Sweden (4%)
Industry Focus
- Health Care
- Medical
- Artificial Intelligence (Ai)
- Software
- Health Diagnostics
- Marketplace
- Medical Device
- Mental Health
- Wellness
- Veterinary
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.